CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti#Oncology #Announces #BestinDisease #Durability #Data #BOND003 #Cohort #Promising #Early #Signal #Cohort #Cretostimogene #Grenadenorepvec #American #Urological #Association #Annual #Meeti